Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.
暂无分享,去创建一个
G. Fontanini | G. Tortora | F. Ciardiello | D. Melisi | F. Zunino | A. Bianco | B. Veneziani | V. Damiano | R. Caputo | Oncologia Sperimentale | Gabriella Fontanini | Franco Zunino